title: Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?
authors.forename: M H
authors.initials: MH
authors.lastname: Vermeer
authors.forename: M W
authors.initials: MW
authors.lastname: Bekkenk
authors.forename: R
authors.initials: R
authors.lastname: Willemze
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D018450:Disease Progression; D006801:Humans; D017730:Ki-1 Antigen / Q000032:analysis; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011379:Prognosis; D012008:Recurrence; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012883:Skin Ulcer / Q000209:etiology / Q000473:pathology
chemical_list: D017730:Ki-1 Antigen